Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

Background To compare the effectiveness of dimethyl fumarate (DMF) with subcutaneous interferon beta-1a (IFNβ-1a) in controlling disease activity in patients with relapsing–remitting Multiple Sclerosis (MS). Methods Clinical and imaging data from patients treated with either IFNβ-1a or DMF for at le...

Full description

Saved in:

Bibliographic Details
Published in:	BMC neurology Vol. 22; no. 1; pp. 1 - 8
Main Authors:	Sattarnezhad, Neda, Healy, Brian C., Baharnoori, Moogeh, Diaz-Cruz, Camilo, Stankiewicz, James, Weiner, Howard L., Chitnis, Tanuja
Format:	Journal Article
Language:	English
Published:	London BioMed Central 11.07.2022 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Clinical trials Cohort Comparative analysis Demographics Demography Dimethyl fumarate Disease activity Drug therapy Effectiveness Gadolinium Interferon Medicine Medicine & Public Health Multiple sclerosis Neurochemistry Neurology Neurosurgery Patient outcomes Patients β-Interferon United States Multiple sclerosis Interferon Disease activity Effectiveness Cohort Dimethyl fumarate
ISSN:	1471-2377, 1471-2377
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!